Significant Role(s) of CXCL12 and the SDF-1 3′A Genetic Variant in the Pathogenesis of Multiple Sclerosis

Publisher： Karger

E-ISSN： 1423-0216|23|4|197-208

ISSN： 1021-7401

Source： Neuroimmunomodulation, Vol.23, Iss.4, 2016-11, pp. : 197-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients

By  

Neuroimmunomodulation, Vol. 23, Iss. 5-6, 2017-04 ,pp. : 345-351

Karger

Access to resources Recommend Favorite

CCL5, CXCL10 and CXCL11 Chemokines in Patients with Active and Stable Relapsing-Remitting Multiple Sclerosis

By  

Neuroimmunomodulation, Vol. 18, Iss. 1, 2010-08 ,pp. : 67-72

Karger

Access to resources Recommend Favorite

The Biological Functions, Structure and Sources of CXCL10 and Its Outstanding Part in the Pathophysiology of Multiple Sclerosis

By  

Neuroimmunomodulation, Vol. 21, Iss. 6, 2014-03 ,pp. : 322-330

Karger

Access to resources Recommend Favorite

Concentration of Soluble Adhesion Molecules (sVCAM-1, sICAM-1 and sL-Selectin) in the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis and Systemic Lupus erythematosus with Central Nervous Involvement

By  

Neuroimmunomodulation, Vol. 9, Iss. 1, 2001-06 ,pp. : 49-54

Karger

Access to resources Recommend Favorite

Role of Amyloid from a Multiple Sclerosis Perspective: A Literature Review

By  

Neuroimmunomodulation, Vol. 22, Iss. 6, 2015-0 ,pp. : 343-346

Karger

Access to resources Recommend Favorite